Relationship between Obsessive-Compulsive Symptoms and Anxiety Levels during the COVID-19 Pandemic in Healthcare Professionals vs. Non-Healthcare Professionals

Kurhan, Faruk; Kamış, Gülsüm Zuhal; Çim, Emine Füsun Akyüz; Atlı, Abdullah; Dinc, Dilem

doi:10.32604/ijmhp.2022.019013

Cited by 1 publication

(1 citation statement)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In another study in which COVID-19 patients were evaluated by self-report at a one-month follow-up after treatment; symptoms were found to be 28% for PTSD, 31% for depression, 42% for anxiety, 20% for OCD symptoms, and 40% for insomnia. In general, 56% of the patients scored in the pathological interval in at least one psychiatric clinical diagnosis (12,13).…”

Section: Introductionmentioning

confidence: 99%

Psychiatric Symptoms in Covid-19 Patients and Factors Associated With These Symptoms: Could Peripheral Inflammation Markers Be One of Them ?

Gökçen,

Akkuş,

Erturhan

et al. 2024

Kocatepe Tıp Dergisi

View full text Add to dashboard Cite

OBJECTIVE: In addition to respiratory symptoms, there have been reports of increased psychiatric symptoms in COVID-19 patients. In this study, it is aimed to reveal the psychiatric symptoms seen in COVID-19 patients. We also investigated the relationship between these psychiatric symptoms and peripheral inflammatory markers. MATERIAL AND METHODS: The patients were evaluated with "Interview Forms" specially created by the researchers for the study. DSM-V Acute Stress Disorder Scale (ASDS); Perceived Stress Scale-10 (PSS-10); State-Trait Anxiety Inventory (STAI-T/S); and finally Hospital Anxiety and Depression Scale (HADS) were used to determine patients' acute and perceived stress levels, depression and anxiety symptoms, state and generalized anxiety levels, and how these psychiatric symptoms were affected by different social conditions. D-dimer, fibrinogen, lymphocytes, CRP (C-reactive protein) and ferritin levels were taken into account as inflammatory markers. RESULTS: Our study included 108 inpatients and 31 outpatients with COVID-19. The ASDS, STAI State Scale, and HADS depression scale scores of inpatients patients were found to be higher compared to outpatient patients. Increased fibrinogen levels in blood tests were found to predict higher acute stress disorder scores. HAD-Depression subscale and fibrinogen levels were also found to be positively correlated with each other. CONCLUSIONS: Stress, depression and anxiety symptoms accompany COVID-19. In addition, high fibrinogen levels may be associated with psychiatric symptoms. Psychiatric symptoms are indirectly affected by physical illnesses. We can say that a pandemic that causes fear and anxiety all over the world may suppress the immune system in individuals and the suppressed immune system may indirectly make the infection more complicated.

show abstract

Section: Introductionmentioning

confidence: 99%